FMC Stock Recent News

FMC is trading near decade-low levels, offering a compelling margin of safety even with conservative growth assumptions and current cyclical headwinds. The company's financial position remains solid, with manageable debt and strong free cash flow potential once working capital normalizes. Dividend yield is attractive at over 6%, though a cut to a more sustainable level is possible in the near-term, but would still offer appealing income.

Examine the evolution of FMC's (FMC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Investors interested in Agriculture - Operations stocks are likely familiar with FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?

Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

PHILADELPHIA , July 31, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced it has received registration for Fundatis® herbicide powered by Isoflex® active in Great Britain for use in winter wheat and winter barley. Isoflex® active is a novel herbicide when used in cereals and is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide.

FMC Corporation (NYSE:FMC ) Q2 2025 Earnings Conference Call July 31, 2025 9:00 AM ET Company Participants Andrew D. Sandifer - Executive VP & CFO Curt Brooks - Director of Investor Relations Pierre R.

FMC posts better-than-expected Q2 results as higher volumes offset price declines.

FMC (FMC) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.63 per share a year ago.

Agrichemicals company FMC Corp said on Wednesday it intends to divest its commercial business in India, in response to challenges in the country.

Maintains full year adjusted EBITDA and adjusted EPS guidance; announces sale of India commercial business Second Quarter 2025 Highlights Revenue of $1.05 billion, up 1 percent versus Q2 2024, up 2 percent organically1 Consolidated GAAP net income of $67 million, a decline of 77 percent versus Q2 2024 Adjusted EBITDA of $207 million, up 2 percent versus Q2 2024 Consolidated GAAP net income of $0.53 per diluted share, down 77 percent versus Q2 2024 Adjusted earnings per diluted share of $0.69, an increase of 10 percent versus Q2 2024 Full-Year Outlook 2 Revenue outlook of $4.08 billion to $4.28 billion, excluding India, down 2 percent at the midpoint versus 2024 reported results, which included India Maintains adjusted EBITDA outlook of $870 million to $950 million, an increase of 1 percent versus prior year at the midpoint Adjusted earnings per diluted share outlook unchanged at $3.26 to $3.70, flat at the midpoint to prior year Free cash flow forecast remains $200 million to $400 mill